Mounjaro: Eli Lilly launches popular weight-loss drug in India
The single-dose vial presentation has marketing authorization from the national drugs regulator—Central Drugs Standard ...
Eli Lilly brings much-awaited weight-loss drug Mounjaro to India
The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...
The Print on MSN9 小时
Fat-busting drug Mounjaro launched in India. Here’s how much it will cost
US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...
Express Healthcare9 小时
Eli Lilly launches Mounjaro in India for obesity and type 2 diabetes
Mounjaro is approved as an adjunct to a reduced-calorie diet and increased physical activity for adults with an initial body ...
Eli Lilly launches weight-loss drug Mounjaro in India at competitive pricing
US pharmaceutical giant Eli Lilly has launched its blockbuster diabetes and weight-loss drug, Mounjaro, in India following ...
Medscape20 小时
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium ...
Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...